On Invalid Date, Vera Therapeutics (NASDAQ: VERA) reported Q3 2023 earnings per share (EPS) of -$0.45, up 50.55% year over year. Total Vera Therapeutics earnings for the quarter were -$20.10 million. In the same quarter last year, Vera Therapeutics's earnings per share (EPS) was -$0.91.
As of Q4 2023, Vera Therapeutics's earnings has grown year over year. Vera Therapeutics's earnings in the past year totalled -$102.77 million.
What was VERA's revenue last quarter?
On Invalid Date, Vera Therapeutics (NASDAQ: VERA) reported Q3 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Vera Therapeutics's revenue was $0.00.
What was VERA's revenue growth in the past year?
As of Q4 2023, Vera Therapeutics's revenue has grown null year over year. Vera Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.